Nigeria Expands Cancer Care with New Research Initiatives

Dr. Lolad Adeyemi, Special Assistant for Research and Innovation at the Ministry of State for Health, announced Nigeria's progress in cancer treatment and research. The country has launched its first three immunotherapy clinics, providing access to key cancer drugs like Keytruda (nivolumab) at no cost to participating patients.

This development marks a significant milestone driven by local research, eliminating the need for patients to travel abroad for advanced treatment. Dr. Juli Gralow, Chief Medical Officer of the American Society of Clinical Oncology (ASCO), emphasized the importance of bridging the gap in global cancer research and highlighted the low participation of African patients in clinical trials.

Miriam Mutebi, a breast cancer surgeon and immediate past president of AORTIC, called for increased domestic funding and stronger political commitment to cancer research, urging African governments to invest in locally driven research to enhance patient education and healthcare systems.